Company Filing History:
Years Active: 2014
Title: Tim Cao: Innovator in Antibody Development
Introduction
Tim Cao is an accomplished inventor based in Millbrae, California, known for his significant contributions to the field of biotechnology. He holds a notable patent that focuses on anti-LRP6 antibodies, which offers innovative methods for therapeutic applications in cellular signaling.
Latest Patents
Tim's patent, titled "Anti-LRP6 antibodies," involves the development of antibodies that target the LRP6 receptor. This invention not only provides novel anti-LRP6 antibodies but also encompasses methods for utilizing these antibodies in various therapeutic contexts. A key highlight of this patent is the introduction of bispecific anti-LRP6 antibodies that effectively inhibit signaling from multiple Wnt isoforms, expanding the potential for treatment options.
Career Highlights
Currently, Tim Cao works at Genentech, Inc., a leader in biotechnology that focuses on discovering and developing innovative medicines. His role at Genentech has allowed him to collaborate on various groundbreaking projects that advance the understanding and treatment of diseases through innovative therapeutic strategies.
Collaborations
Tim has had the opportunity to work alongside talented colleagues such as Eric Bourhis and Rick Carano. Their collaborative efforts at Genentech have fostered an environment of innovation where novel ideas can flourish and lead to meaningful advancements in the field of biotechnology.
Conclusion
Tim Cao's work exemplifies the spirit of innovation in the biotechnology sector. With his patent on anti-LRP6 antibodies, he is poised to make a significant impact in therapeutic development. As part of Genentech's team, Tim continues to push the boundaries of science, paving the way for future breakthroughs in healthcare and medicine.